Unraveling Immune Mechanisms in Reproductive Health – Reproduction and Fertility
Reproduction and Fertility shared a post on LinkedIn:
“Day 2 of RaFJC – Immune Adaptation from Conception to Pregnancy
After exploring how ovulation itself is an immune‑regulated event, with inflammatory mediators shaping oocyte release and follicle competence, today we move forward in the reproductive timeline: conception and implantation: immune cross-talk determines whether the embryo is accepted or rejected.
Immune and Inflammatory Responses at Implantation
- During differentiation, the blastocyst expresses L-selectins (a cell adhesion molecule that facilitates the initial ‘tethering’ and ‘rolling’ of leukocytes. L-selectins interact with L-selectin ligands, which are expressed mainly on pinopodes during the implantation window.
- During apposition and the adhesion phase, the blastocyst promotes cleavage of Mucin-1, which drives the implantation window and ensures successful attachment. Cytokines such as Leukemia inhibitory factor (LIF) play an important role during human implantation by supporting the embryo-endometrial interactions.
- During the invasion phase, the trophoblast cells penetrate the endometrial epithelium into the stroma. The extra-villous trophoblast cells proliferate and differentiate into inner cytotrophoblast and outer syncytiotrophoblast.
- When implantation begins, the embryo breaches the luminal epithelium, and the surrounding stromal cells transform into decidual cells. Immune cells, such as macrophages and uterine natural killer (uNK) cells, play an important role during decidualization by promoting an environment conducive to successful implantation.
Dysregulation of these pathways is linked to implantation failure, recurrent miscarriage, and pregnancy complications.
Implantation is not passive! It’s an immune dialogue between the embryo and the endometrium. Understanding this dialogue is critical for improving fertility treatments and predicting pregnancy outcomes.
What immune mechanisms at implantation deserve more attention in reproductive medicine? How can we better translate these findings into clinical practice? We would love to hear your thoughts in the comments.
Are you interested in this topic? Explore our next Serial Collection: Immune Regulation and Inflammatory Mechanisms in Reproductive Health and Disease, and submit your article to be a part of it.
Tomorrow we’ll be extending this discussion into pregnancy and delivery, highlighting maternal immune adaptations – stay tuned!”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 14, 2026, 17:13Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary – IJGC
-
May 14, 2026, 17:11Christopher Robinson: Isolated Severe Systolic Hypertension During Delivery Admission and Maternal Outcomes
-
May 14, 2026, 17:08Ally Murji: Honoured to Deliver the 51st Annual RT Weaver Lecture at McMaster University
-
May 14, 2026, 17:00Your Hair Dye Could Be Affecting Your Fertility – Fertility Plus
-
May 14, 2026, 16:53Devora Lieberman on Reduced-Tip Needle Design and Its Role in Egg Collection for Older Women – City Fertility
-
May 14, 2026, 16:48AI Can Watch Your IVF Embryo Grow and Predict If It’s Chromosomally Normal, Without Any Biopsy – Fertility Plus
-
May 14, 2026, 12:04Asma Khalil: Why Twin Pregnancies Need More Than Routine Monitoring?
-
May 14, 2026, 12:01Marco Zaccaria: Why Distension Media Selection Matters in Modern Hysteroscopy
-
May 14, 2026, 11:58Mathew Leonardi: PCOS Has Been Renamed to PMOS and It Changes How We Understand the Disease